| M01AB55 - Diclofenac, Combinations | ATC-DDD Version 2016. Source: WHO | | M - Musculo-Skeletal System | | |
| | M01 - Antiinflammatory and Antirheumatic Products | Corticosteroids, see H02 - Corticosteroids for systemic use.
|
| | M01A - Antiinflammatory and Antirheumatic Products, Non-Steroids | This group comprises antiinflammatory and antirheumatic preparations for systemic use.
The substances in this group have a broad range of indications, however, they should be kept together in M01A.
NSAIDs in combination with paracetamol are classified in N02BE.
Disease Modifying Antirheumatic Drugs (DMARDs) see:
A07EC - Aminosalicylic acid and similar agents
L01BA - Folic acid analogues
L04AA - Selective immunosuppressants
L04AX - Other immunosuppressants
M01C - Specific antirheumatic agents
P01BA - Aminoquinolines
All preparations containing salicylic acid and derivatives are classified in N02BA - Salicylic acid and derivatives, as it is difficult to differentiate between use of salicylates in rheumatic conditions and other therapeutic uses.
Exception: Salicylates in combination with corticosteroids are classified in M01B.
Combinations of antiinflammatory/antirheumatic agents (e.g. corticosteroids) are classified in M01B.
Combinations with muscle relaxants are classified in M03B.
Combinations with antibacterials are classified in J01.
Antiinflammatory or antirheumatic agents in combination with opioids are classified in N02AJ - Opioids in combination with non-opioid analgesics.
Combined cold preparations with therapeutic levels of antiinflammatory agents are classified in this group at separate 5th levels by using the 50-series.
Combinations with drugs classified in A02B (e.g. esomeprazole) are classified in M01A using the 50-series.
| The DDDs are based on the treatment of rheumatoid arthritis, except for the coxibs (M01AH).
|
| | M01AB - Acetic Acid Derivatives and Related Substances | | |
| | M01AB55 - Diclofenac, Combinations | | Concentr. | Adm.Route | Note |
|---|
| | O | Refers to diclofenac |
|
|
|
|
